CRESCENT BIOPHARMA, INC. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
CRESCENT BIOPHARMA, INC. (CBIO) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of -0.40% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2025-02-13
- CRESCENT BIOPHARMA, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was -0.40%.
- CRESCENT BIOPHARMA, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was -3.50%.
- CRESCENT BIOPHARMA, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was -3.90%.
- CRESCENT BIOPHARMA, INC. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2021 was -0.30%, a 175.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.40% 10-K · filed 2025-02-13 | |
| 2023-12-31 | -3.50% 10-K · filed 2025-02-13 | -1.30% 10-K · filed 2024-03-27 |
| 2022-12-31 | -3.90% 10-K · filed 2024-03-27 | |
| 2021-12-31 | -0.30% 10-K · filed 2024-03-27 | |
| 2020-12-31 | 0.40% 10-K · filed 2023-03-29 | |
| 2019-12-31 | -0.10% 10-K · filed 2022-03-03 | |
| 2018-12-31 | 0.60% 10-K · filed 2021-03-02 | |
| 2017-12-31 | 0.30% 10-K · filed 2020-02-28 | |
| 2014-12-31 | 2.40% 10-K · filed 2017-03-01 | |
| 2013-12-31 | 0.10% 10-K · filed 2016-02-29 | |
| 2012-12-31 | 0.10% 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |